Active ingredientXylazineCat. No. P-X005-001CAS 7361-61-7Family · Pharmaceutical analytical standards
Xylazine
An alpha-2 adrenergic agonist, related to clonidine, used in veterinary medicine as a sedative, analgesic and muscle relaxant in horses, cattle, dogs, cats and deer, often together with ketamine for anaesthesia. This family brings together the active ingredient, metabolites and other impurities.
Did you know?It was discovered in Germany in 1962 as a possible blood pressure medicine; human tests showed strong sedation instead, and from the late 1960s it became a veterinary sedative.
Go to the active ingredient →Active ingredientXylazineCat. No. P-X005-001CAS 7361-61-7
Active ingredientXylazine HydrochlorideCat. No. P-X005-002CAS 23076-35-9
Metabolite4-Hydroxy Xylazine O-GlucuronideCat. No. P-X005-003CAS 1473376-42-9
Metabolite4-Hydroxy Xylazine O-Glucuronide Lithium SaltCat. No. P-X005-004
Impurity2,6-Dimethylphenyl IsothiocyanateCat. No. P-X005-005CAS 19241-16-8
Impurity3-Hydroxy XylazineCat. No. P-X005-006CAS 145356-33-8
Impurity4-Hydroxy XylazineCat. No. P-X005-007CAS 145356-32-7No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceXylazine hydrochloride CRSEDQM code X0075000Family XylazineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.